Form 4: OrbiMed Advisors Reduces Stake in Disc Medicine, Inc. (IRON)

OrbiMed Advisors LLC and related entities report the sale of Disc Medicine, Inc. (IRON) common stock at $54.11 per share.

Summary

• OrbiMed Advisors LLC, along with related entities including OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC, and OrbiMed Genesis GP LLC, filed a Form 4.
• The form indicates a change in beneficial ownership of Disc Medicine, Inc. (IRON) common stock.
• On March 24, 2025, the entities sold shares of common stock at a price of $54.11 per share.
• The sales resulted in a decrease in the number of shares indirectly beneficially owned by the reporting persons.
• The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports a transaction without expressing a positive or negative outlook.

Negatives

• OrbiMed Advisors LLC reduced its stake in Disc Medicine, Inc.

Management Comments

• Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), except to the extent of its pecuniary interest therein, if any.

Industry Context

Form 4 filings are a routine part of insider trading disclosures, providing transparency into the buying and selling activities of company insiders and major shareholders.

Stakeholder Impact

• The sale of shares by a major shareholder like OrbiMed could potentially influence investor sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, OrbiMed Advisors, Disc Medicine, IRON, Stock Sale